Content area
Full Text
http://crossmark.crossref.org/dialog/?doi=10.1007/s00213-016-4282-1&domain=pdf
Web End = Psychopharmacology (2016) 233:23432353 DOI 10.1007/s00213-016-4282-1
http://crossmark.crossref.org/dialog/?doi=10.1007/s00213-016-4282-1&domain=pdf
Web End = http://crossmark.crossref.org/dialog/?doi=10.1007/s00213-016-4282-1&domain=pdf
Web End = http://crossmark.crossref.org/dialog/?doi=10.1007/s00213-016-4282-1&domain=pdf
Web End = http://crossmark.crossref.org/dialog/?doi=10.1007/s00213-016-4282-1&domain=pdf
Web End = http://crossmark.crossref.org/dialog/?doi=10.1007/s00213-016-4282-1&domain=pdf
Web End = http://crossmark.crossref.org/dialog/?doi=10.1007/s00213-016-4282-1&domain=pdf
Web End = http://crossmark.crossref.org/dialog/?doi=10.1007/s00213-016-4282-1&domain=pdf
Web End = ORIGINAL INVESTIGATION
Narcolepsy-like sleep disturbance in orexin knockout mice are normalized by the 5-HT1A receptor agonist 8-OH-DPAT
Tomohisa Mori1,2 & Naoki Uzawa1 & Yoshiyuki Iwase1 & Daiki Masukawa1 &
Mahardian Rahmadi1 & Shigeto Hirayama1 & Mayuna Hokazono1 &
Kimio Higashiyama3 & Seiji Shioda4 & Tsutomu Suzuki1,5
Received: 22 December 2015 /Accepted: 22 March 2016 /Published online: 11 April 2016 # Springer-Verlag Berlin Heidelberg 2016
AbstractRationale Orexin knockout (KO) mice exhibit a phenotype that is similar to human narcolepsy, and monoamine-related compounds, such as psychostimulants and 5-HT uptake inhibitors, have been used for the treatment of narcoleptic disorders. However, little information is available regarding the pathophysiological features of orexin KO mice, particularly with respect to their narcoleptic-like disorder and how it is affected by monoamine-related compounds.
Objectives The present study was designed to investigate both the nature of the neuronal changes in orexin KO mice and the therapeutic effects of monoamine-related compounds on the sleep disorder in orexin KO mice.
Results A decrease in locomotor activity in the dark phase was observed in orexin KO mice, and psychostimulants and 5-HT-related compounds, such as 8-OH-DPAT (5-HT1A re
ceptor agonist) and DOI (5-HT2 receptor agonist), inhibited this hypolocomotion. We also found that 5-HT1A receptor mRNA levels, but not those for 5-HT2 or dopamine receptors, were significantly decreased in the prefrontal cortex of orexin
KO mice in the dark period and were accompanied by compromising the increase in 5-HT metabolite levels. In addition, the sleep disorder in orexin KO mice, as analyzed by a polysomnography during the dark period, was completely normalized by 8-OH-DPAT.
Conclusion These results suggest that a dysfunction of 5-HT1A receptors is involved in the narcoleptic-like sleep dys-function in orexin KO mice, and such dysfunction may participate in orexin deficiency-induced sleep disorders. Further, the use of 5-HT1A receptor agonist could be useful for treating the sleep disorder under a deficiency of orexin.
Keywords Orexin . 5-HT . Dopamine . Narcolepsy
AbbreviationsEEG ElectroencephalogramEMG ElectromyogramKO KnockoutMDMA 3,4-MethylenedioxymethamphetamineREM Rapid eye movementRT-PCR Reverse transcription-polymerase chain reaction TBS Tris-buffered salineTBST TBS containing 0.05 %...